Zions Bancorporation’s Jazz Pharmaceuticals JAZZ Stock Holding History

Zions Bancorporation’s Portfolio JAZZ Stock Details JAZZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-9	Closed	-$1.11K	–	917
2023 Q4	$1.11K	Buy	+9	New	+$1.12K	﹤0.01%	851
2023 Q2	–	Sell	-4	Closed	-$585	–	905
2023 Q1	$585	Hold	4	–	–	﹤0.01%	874
2022 Q4	$637	Buy	+4	New	+$586	﹤0.01%	1021
2021 Q4	–	Sell	-20	Closed	-$3K	–	1030
2021 Q3	$3K	Buy	+20	New	+$3.02K	﹤0.01%	887
2020 Q4	–	Sell	-15	Closed	-$2K	–	985
2020 Q3	$2K	Buy	+15	New	+$1.86K	﹤0.01%	930
2020 Q2	–	Sell	-38	Closed	-$4K	–	954
2020 Q1	$4K	Hold	38	–	–	﹤0.01%	729
2019 Q4	$6K	Hold	38	–	–	﹤0.01%	782
2019 Q3	$5K	Hold	38	–	–	﹤0.01%	782
2019 Q2	$5K	Hold	38	–	–	﹤0.01%	729
2019 Q1	$5K	Sell	38 -8	-17%	-$1.04K	﹤0.01%	772
2018 Q4	$6K	Sell	46 -9	-16%	-$1.33K	﹤0.01%	369
2018 Q3	$9K	Hold	55	–	–	﹤0.01%	572
2018 Q2	$9K	Buy	+55	New	+$8.99K	0.01%	334
2017 Q4	–	Sell	-56	Closed	-$8K	–	793
2017 Q3	$8K	Buy	+56	New	+$8.47K	﹤0.01%	872
2017 Q1	–	Sell	-38	Closed	-$4K	–	779
2016 Q4	$4K	Buy	38 +15	+65%	+$1.67K	﹤0.01%	660
2016 Q3	$3K	Buy	+23	New	+$3.1K	﹤0.01%	670
2016 Q1	–	Sell	-10	Closed	-$1K	–	880
2015 Q4	$1K	Hold	10	–	–	﹤0.01%	789
2015 Q3	$1K	Buy	+10	New	+$1.72K	﹤0.01%	803

Other funds holding JAZZ

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

PCM

Polaris Capital Management Boston, Massachusetts $1.06B AUM 40.82% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

Pacer Advisors Malvern, Pennsylvania $39.3B AUM 27.96% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Zions Bancorporation's JAZZ Position: Q1 2024 in Review

Zions Bancorporation sold out of Jazz Pharmaceuticals (JAZZ) in Q1 2024, closing a stake of 9 shares — an estimated $1.11K sold.

Zions Bancorporation first reported a position in JAZZ in Q3 2015 and held it in 18 quarters. The position peaked at $9K in Q3 2018. 481 funds tracked by Wall St. Rank hold JAZZ as of Q1 2024.

Zions Bancorporation reported no remaining Jazz Pharmaceuticals position as of Q1 2024 after selling out during the quarter.
Zions Bancorporation sold 9 Jazz Pharmaceuticals shares in Q1 2024, an estimated $1.11K.
Zions Bancorporation first reported a position in Jazz Pharmaceuticals in Q3 2015 and held it in 18 quarters.
Zions Bancorporation's Jazz Pharmaceuticals position peaked at $9K in Q3 2018.
481 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q1 2024.

Based on Zions Bancorporation's 13F filing for Q1 2024, filed 14 May 2024.